Followers | 221 |
Posts | 12609 |
Boards Moderated | 0 |
Alias Born | 03/15/2013 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 07, 2023 6:39:39 PM
Recent LUMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:08:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:06:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:09:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:02:28 PM
- Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024 • GlobeNewswire Inc. • 06/04/2024 01:00:00 PM
- Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 • GlobeNewswire Inc. • 05/20/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:57:40 PM
- Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/14/2024 08:15:00 PM
- Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024 • GlobeNewswire Inc. • 05/09/2024 06:51:02 PM
- Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
- Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:48:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:44:25 PM
- Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update • GlobeNewswire Inc. • 03/07/2024 09:01:00 PM
- Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024 • GlobeNewswire Inc. • 02/26/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 10:22:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 09:02:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:55:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:54:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:53:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:52:48 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM